Supplementary Figures from Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors Article Swipe
Esra A. Akbay
,
Shohei Koyama
,
Julián Carretero
,
Abigail Altabef
,
Jeremy H. Tchaicha
,
Camilla L. Christensen
,
Oliver R. Mikse
,
Andrew D. Cherniack
,
Ellen M. Beauchamp
,
Trevor J. Pugh
,
Matthew D. Wilkerson
,
Peter E. Fecci
,
Mohit Butaney
,
Jacob B. Reibel
,
Margaret Soucheray
,
Travis J. Cohoon
,
Pasi A. Jänne
,
Matthew Meyerson
,
D. Neil Hayes
,
Geoffrey I. Shapiro
,
Takeshi Shimamura
,
Lynette M. Sholl
,
Scott J. Rodig
,
Gordon J. Freeman
,
Peter S. Hammerman
,
Glenn Dranoff
,
Kwok‐Kin Wong
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/2159-8290.22530267.v1
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/2159-8290.22530267.v1
- PDF file 2020K, Supplementary figures 1-11. For the mouse experiments tumor bearing lungs were classified as mildly sick and severely sick based on the tumor burden as determined by right lung lobe weights. Oncogene induced immunosuppressive environment manifested as compromised T cell function, elevation in the levels of tumor promoting cytokines, and changes in lung hematopoietic population was observed in the mildy sick mice in addition to the severely sick EGFR mutant mice. Anti PD-1 antibody treatment did not show efficacy in the Kras driven tumors despite the expression of the PD-1 ligand
Related Topics
Concepts
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/2159-8290.22530267.v1
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4362482225
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4362482225Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/2159-8290.22530267.v1Digital Object Identifier
- Title
-
Supplementary Figures from Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung TumorsWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-04-03Full publication date if available
- Authors
-
Esra A. Akbay, Shohei Koyama, Julián Carretero, Abigail Altabef, Jeremy H. Tchaicha, Camilla L. Christensen, Oliver R. Mikse, Andrew D. Cherniack, Ellen M. Beauchamp, Trevor J. Pugh, Matthew D. Wilkerson, Peter E. Fecci, Mohit Butaney, Jacob B. Reibel, Margaret Soucheray, Travis J. Cohoon, Pasi A. Jänne, Matthew Meyerson, D. Neil Hayes, Geoffrey I. Shapiro, Takeshi Shimamura, Lynette M. Sholl, Scott J. Rodig, Gordon J. Freeman, Peter S. Hammerman, Glenn Dranoff, Kwok‐Kin WongList of authors in order
- Landing page
-
https://doi.org/10.1158/2159-8290.22530267.v1Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/2159-8290.22530267.v1Direct OA link when available
- Concepts
-
KRAS, Lung, Cancer research, Immune system, Population, Medicine, PD-L1, Oncogene, Immunology, Internal medicine, Biology, Immunotherapy, Cancer, Cell cycle, Colorectal cancer, Environmental healthTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4362482225 |
|---|---|
| doi | https://doi.org/10.1158/2159-8290.22530267.v1 |
| ids.doi | https://doi.org/10.1158/2159-8290.22530267.v1 |
| ids.openalex | https://openalex.org/W4362482225 |
| fwci | |
| type | preprint |
| title | Supplementary Figures from Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10158 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9994999766349792 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | Cancer Immunotherapy and Biomarkers |
| topics[1].id | https://openalex.org/T12334 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9990000128746033 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | Lung Cancer Research Studies |
| topics[2].id | https://openalex.org/T11020 |
| topics[2].field.id | https://openalex.org/fields/24 |
| topics[2].field.display_name | Immunology and Microbiology |
| topics[2].score | 0.9973999857902527 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2403 |
| topics[2].subfield.display_name | Immunology |
| topics[2].display_name | Immune Cell Function and Interaction |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2781187634 |
| concepts[0].level | 4 |
| concepts[0].score | 0.7376076579093933 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q20969980 |
| concepts[0].display_name | KRAS |
| concepts[1].id | https://openalex.org/C2777714996 |
| concepts[1].level | 2 |
| concepts[1].score | 0.5667099356651306 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q7886 |
| concepts[1].display_name | Lung |
| concepts[2].id | https://openalex.org/C502942594 |
| concepts[2].level | 1 |
| concepts[2].score | 0.5511158108711243 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[2].display_name | Cancer research |
| concepts[3].id | https://openalex.org/C8891405 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5201233625411987 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[3].display_name | Immune system |
| concepts[4].id | https://openalex.org/C2908647359 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5021870136260986 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q2625603 |
| concepts[4].display_name | Population |
| concepts[5].id | https://openalex.org/C71924100 |
| concepts[5].level | 0 |
| concepts[5].score | 0.44039663672447205 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[5].display_name | Medicine |
| concepts[6].id | https://openalex.org/C2781053074 |
| concepts[6].level | 4 |
| concepts[6].score | 0.4167579412460327 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q21100639 |
| concepts[6].display_name | PD-L1 |
| concepts[7].id | https://openalex.org/C2781018059 |
| concepts[7].level | 4 |
| concepts[7].score | 0.41159212589263916 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q207609 |
| concepts[7].display_name | Oncogene |
| concepts[8].id | https://openalex.org/C203014093 |
| concepts[8].level | 1 |
| concepts[8].score | 0.3881620168685913 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[8].display_name | Immunology |
| concepts[9].id | https://openalex.org/C126322002 |
| concepts[9].level | 1 |
| concepts[9].score | 0.3392818570137024 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[9].display_name | Internal medicine |
| concepts[10].id | https://openalex.org/C86803240 |
| concepts[10].level | 0 |
| concepts[10].score | 0.33831000328063965 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[10].display_name | Biology |
| concepts[11].id | https://openalex.org/C2777701055 |
| concepts[11].level | 3 |
| concepts[11].score | 0.19448012113571167 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q1427096 |
| concepts[11].display_name | Immunotherapy |
| concepts[12].id | https://openalex.org/C121608353 |
| concepts[12].level | 2 |
| concepts[12].score | 0.1895873248577118 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[12].display_name | Cancer |
| concepts[13].id | https://openalex.org/C29537977 |
| concepts[13].level | 3 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q188941 |
| concepts[13].display_name | Cell cycle |
| concepts[14].id | https://openalex.org/C526805850 |
| concepts[14].level | 3 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q188874 |
| concepts[14].display_name | Colorectal cancer |
| concepts[15].id | https://openalex.org/C99454951 |
| concepts[15].level | 1 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q932068 |
| concepts[15].display_name | Environmental health |
| keywords[0].id | https://openalex.org/keywords/kras |
| keywords[0].score | 0.7376076579093933 |
| keywords[0].display_name | KRAS |
| keywords[1].id | https://openalex.org/keywords/lung |
| keywords[1].score | 0.5667099356651306 |
| keywords[1].display_name | Lung |
| keywords[2].id | https://openalex.org/keywords/cancer-research |
| keywords[2].score | 0.5511158108711243 |
| keywords[2].display_name | Cancer research |
| keywords[3].id | https://openalex.org/keywords/immune-system |
| keywords[3].score | 0.5201233625411987 |
| keywords[3].display_name | Immune system |
| keywords[4].id | https://openalex.org/keywords/population |
| keywords[4].score | 0.5021870136260986 |
| keywords[4].display_name | Population |
| keywords[5].id | https://openalex.org/keywords/medicine |
| keywords[5].score | 0.44039663672447205 |
| keywords[5].display_name | Medicine |
| keywords[6].id | https://openalex.org/keywords/pd-l1 |
| keywords[6].score | 0.4167579412460327 |
| keywords[6].display_name | PD-L1 |
| keywords[7].id | https://openalex.org/keywords/oncogene |
| keywords[7].score | 0.41159212589263916 |
| keywords[7].display_name | Oncogene |
| keywords[8].id | https://openalex.org/keywords/immunology |
| keywords[8].score | 0.3881620168685913 |
| keywords[8].display_name | Immunology |
| keywords[9].id | https://openalex.org/keywords/internal-medicine |
| keywords[9].score | 0.3392818570137024 |
| keywords[9].display_name | Internal medicine |
| keywords[10].id | https://openalex.org/keywords/biology |
| keywords[10].score | 0.33831000328063965 |
| keywords[10].display_name | Biology |
| keywords[11].id | https://openalex.org/keywords/immunotherapy |
| keywords[11].score | 0.19448012113571167 |
| keywords[11].display_name | Immunotherapy |
| keywords[12].id | https://openalex.org/keywords/cancer |
| keywords[12].score | 0.1895873248577118 |
| keywords[12].display_name | Cancer |
| language | en |
| locations[0].id | doi:10.1158/2159-8290.22530267.v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/2159-8290.22530267.v1 |
| locations[1].id | pmh:oai:figshare.com:article/22530267 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306400572 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[1].source.host_organization | https://openalex.org/I196829312 |
| locations[1].source.host_organization_name | La Trobe University |
| locations[1].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[1].license | cc-by |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | https://openalex.org/licenses/cc-by |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://figshare.com/articles/journal_contribution/Supplementary_Figures_from_Activation_of_the_PD-1_Pathway_Contributes_to_Immune_Escape_in_EGFR-Driven_Lung_Tumors/22530267 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5012107830 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-4149-2529 |
| authorships[0].author.display_name | Esra A. Akbay |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Esra A. Akbay |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5030855728 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-6897-9417 |
| authorships[1].author.display_name | Shohei Koyama |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Shohei Koyama |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5073057802 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-7269-8506 |
| authorships[2].author.display_name | Julián Carretero |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Julian Carretero |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5057294444 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Abigail Altabef |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Abigail Altabef |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5076790826 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-3451-3392 |
| authorships[4].author.display_name | Jeremy H. Tchaicha |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Jeremy H. Tchaicha |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5013721197 |
| authorships[5].author.orcid | https://orcid.org/0009-0007-3313-2615 |
| authorships[5].author.display_name | Camilla L. Christensen |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Camilla L. Christensen |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5019041602 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Oliver R. Mikse |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Oliver R. Mikse |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5030622261 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-0470-0111 |
| authorships[7].author.display_name | Andrew D. Cherniack |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Andrew D. Cherniack |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5110596383 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Ellen M. Beauchamp |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Ellen M. Beauchamp |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5072207500 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-8073-5888 |
| authorships[9].author.display_name | Trevor J. Pugh |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Trevor J. Pugh |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5103006571 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-0444-1642 |
| authorships[10].author.display_name | Matthew D. Wilkerson |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Matthew D. Wilkerson |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5027211051 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-2912-8695 |
| authorships[11].author.display_name | Peter E. Fecci |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Peter E. Fecci |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5028909262 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-4760-4026 |
| authorships[12].author.display_name | Mohit Butaney |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Mohit Butaney |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5091171014 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-6047-6276 |
| authorships[13].author.display_name | Jacob B. Reibel |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Jacob B. Reibel |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5025723984 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-0370-6653 |
| authorships[14].author.display_name | Margaret Soucheray |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Margaret Soucheray |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5009011087 |
| authorships[15].author.orcid | https://orcid.org/0000-0001-9951-8755 |
| authorships[15].author.display_name | Travis J. Cohoon |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Travis J. Cohoon |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5048675362 |
| authorships[16].author.orcid | https://orcid.org/0000-0002-7821-4928 |
| authorships[16].author.display_name | Pasi A. Jänne |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Pasi A. Janne |
| authorships[16].is_corresponding | False |
| authorships[17].author.id | https://openalex.org/A5056373767 |
| authorships[17].author.orcid | https://orcid.org/0000-0002-9133-8108 |
| authorships[17].author.display_name | Matthew Meyerson |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Matthew Meyerson |
| authorships[17].is_corresponding | False |
| authorships[18].author.id | https://openalex.org/A5054164329 |
| authorships[18].author.orcid | |
| authorships[18].author.display_name | D. Neil Hayes |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | D. Neil Hayes |
| authorships[18].is_corresponding | False |
| authorships[19].author.id | https://openalex.org/A5045419282 |
| authorships[19].author.orcid | https://orcid.org/0000-0002-3331-4095 |
| authorships[19].author.display_name | Geoffrey I. Shapiro |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Geoffrey I. Shapiro |
| authorships[19].is_corresponding | False |
| authorships[20].author.id | https://openalex.org/A5012904104 |
| authorships[20].author.orcid | https://orcid.org/0000-0002-5402-7204 |
| authorships[20].author.display_name | Takeshi Shimamura |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Takeshi Shimamura |
| authorships[20].is_corresponding | False |
| authorships[21].author.id | https://openalex.org/A5090956629 |
| authorships[21].author.orcid | https://orcid.org/0000-0002-9532-9735 |
| authorships[21].author.display_name | Lynette M. Sholl |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Lynette M. Sholl |
| authorships[21].is_corresponding | False |
| authorships[22].author.id | https://openalex.org/A5058975989 |
| authorships[22].author.orcid | https://orcid.org/0000-0003-1761-9769 |
| authorships[22].author.display_name | Scott J. Rodig |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Scott J. Rodig |
| authorships[22].is_corresponding | False |
| authorships[23].author.id | https://openalex.org/A5075310347 |
| authorships[23].author.orcid | https://orcid.org/0000-0002-7210-5616 |
| authorships[23].author.display_name | Gordon J. Freeman |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | Gordon J. Freeman |
| authorships[23].is_corresponding | False |
| authorships[24].author.id | https://openalex.org/A5004171995 |
| authorships[24].author.orcid | https://orcid.org/0009-0006-9143-899X |
| authorships[24].author.display_name | Peter S. Hammerman |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | Peter S. Hammerman |
| authorships[24].is_corresponding | False |
| authorships[25].author.id | https://openalex.org/A5028608171 |
| authorships[25].author.orcid | https://orcid.org/0000-0002-2341-7517 |
| authorships[25].author.display_name | Glenn Dranoff |
| authorships[25].author_position | middle |
| authorships[25].raw_author_name | Glenn Dranoff |
| authorships[25].is_corresponding | False |
| authorships[26].author.id | https://openalex.org/A5019034689 |
| authorships[26].author.orcid | https://orcid.org/0000-0001-6323-235X |
| authorships[26].author.display_name | Kwok‐Kin Wong |
| authorships[26].author_position | last |
| authorships[26].raw_author_name | Kwok-Kin Wong |
| authorships[26].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/2159-8290.22530267.v1 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Supplementary Figures from Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10158 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9994999766349792 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | Cancer Immunotherapy and Biomarkers |
| related_works | https://openalex.org/W3030972949, https://openalex.org/W4283712951, https://openalex.org/W4229832877, https://openalex.org/W4306404900, https://openalex.org/W3111812619, https://openalex.org/W4248366929, https://openalex.org/W2590035663, https://openalex.org/W2914997899, https://openalex.org/W4229670017, https://openalex.org/W4226309907 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1158/2159-8290.22530267.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/2159-8290.22530267.v1 |
| primary_location.id | doi:10.1158/2159-8290.22530267.v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/2159-8290.22530267.v1 |
| publication_date | 2023-04-03 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.T | 41 |
| abstract_inverted_index.as | 16, 27, 39 |
| abstract_inverted_index.by | 29 |
| abstract_inverted_index.in | 45, 54, 60, 65, 82 |
| abstract_inverted_index.of | 48, 90 |
| abstract_inverted_index.on | 23 |
| abstract_inverted_index.to | 67 |
| abstract_inverted_index.For | 7 |
| abstract_inverted_index.PDF | 1 |
| abstract_inverted_index.and | 19, 52 |
| abstract_inverted_index.did | 78 |
| abstract_inverted_index.not | 79 |
| abstract_inverted_index.the | 8, 24, 46, 61, 68, 83, 88, 91 |
| abstract_inverted_index.was | 58 |
| abstract_inverted_index.Anti | 74 |
| abstract_inverted_index.EGFR | 71 |
| abstract_inverted_index.Kras | 84 |
| abstract_inverted_index.PD-1 | 75, 92 |
| abstract_inverted_index.cell | 42 |
| abstract_inverted_index.file | 2 |
| abstract_inverted_index.lobe | 32 |
| abstract_inverted_index.lung | 31, 55 |
| abstract_inverted_index.mice | 64 |
| abstract_inverted_index.show | 80 |
| abstract_inverted_index.sick | 18, 21, 63, 70 |
| abstract_inverted_index.were | 14 |
| abstract_inverted_index.1-11. | 6 |
| abstract_inverted_index.based | 22 |
| abstract_inverted_index.lungs | 13 |
| abstract_inverted_index.mice. | 73 |
| abstract_inverted_index.mildy | 62 |
| abstract_inverted_index.mouse | 9 |
| abstract_inverted_index.right | 30 |
| abstract_inverted_index.tumor | 11, 25, 49 |
| abstract_inverted_index.2020K, | 3 |
| abstract_inverted_index.burden | 26 |
| abstract_inverted_index.driven | 85 |
| abstract_inverted_index.levels | 47 |
| abstract_inverted_index.mildly | 17 |
| abstract_inverted_index.mutant | 72 |
| abstract_inverted_index.tumors | 86 |
| abstract_inverted_index.bearing | 12 |
| abstract_inverted_index.changes | 53 |
| abstract_inverted_index.despite | 87 |
| abstract_inverted_index.figures | 5 |
| abstract_inverted_index.induced | 35 |
| abstract_inverted_index.Oncogene | 34 |
| abstract_inverted_index.addition | 66 |
| abstract_inverted_index.antibody | 76 |
| abstract_inverted_index.efficacy | 81 |
| abstract_inverted_index.observed | 59 |
| abstract_inverted_index.severely | 20, 69 |
| abstract_inverted_index.weights. | 33 |
| abstract_inverted_index.elevation | 44 |
| abstract_inverted_index.function, | 43 |
| abstract_inverted_index.promoting | 50 |
| abstract_inverted_index.treatment | 77 |
| abstract_inverted_index.<p>- | 0 |
| abstract_inverted_index.classified | 15 |
| abstract_inverted_index.cytokines, | 51 |
| abstract_inverted_index.determined | 28 |
| abstract_inverted_index.expression | 89 |
| abstract_inverted_index.manifested | 38 |
| abstract_inverted_index.population | 57 |
| abstract_inverted_index.compromised | 40 |
| abstract_inverted_index.environment | 37 |
| abstract_inverted_index.experiments | 10 |
| abstract_inverted_index.Supplementary | 4 |
| abstract_inverted_index.hematopoietic | 56 |
| abstract_inverted_index.ligand</p> | 93 |
| abstract_inverted_index.immunosuppressive | 36 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 27 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7900000214576721 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.24412675 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |